Evidence map›Paper›PMID 42124416›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2026

[Neuroregulatory Mechanisms of Lung Cancer Progression and Clinical Treatment 
Challenges from the Perspective of Cancer Neuroscience].

Na Wang, Bo Zhang, Lihan Shang, Xuerui Wang, Xiaoshan Wang, Qiyu Fan, Chaoran Wang, Fanming Kong

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Na WangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Bo ZhangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Lihan ShangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Xuerui WangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Xiaoshan WangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Qiyu FanFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Chaoran WangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.
Fanming KongFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin 300381, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer morbidity and mortality worldwide. A highly complex bidirectional regulatory relationship exists between lung cancer progression and the nervous system. The nervous system is believed to play a pivotal regulatory role in the genesis of lung cancer. It is involved in regulating malignant biological behaviors such as proliferation, local invasion, and distant metastasis of lung cancer cells via core mediating pathways involving neurons, neurotransmitters, and neuroactive molecules. At the same time, lung cancer itself and related therapeutic interventions are capable of inducing reverse structural and functional reprogramming within the nervous system. The emergence of cancer neuroscience as a novel interdisciplinary field offers a new perspective to overcome the current bottlenecks in lung cancer treatment, yet it also faces numerous theoretical and clinical challenges that urgently require resolution. This article systematically reviews the intricate relationship between the nervous system and lung cancer progression, focusing on the potential effects and molecular mechanisms of clinical strategies including local therapies, chemotherapy, immunotherapy, and targeted therapy on the nervous system, with the aim of clarifying research opportunities and key challenges in this field and providing a theoretical foundation and practical reference for optimizing the precision treatment system of lung cancer and improving clinical efficacy.
.

Indexed as

Lung NeoplasmsAnimalsDisease ProgressionHumansLung neoplasmsNeuroactive moleculeNeuro-oncologyNeuroscience

Identifiers

PMID42124416
PMCPMC13168002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.